RBC Capital Reiterates Outperform on Abbvie (ABBV) Ahead of Numerous Catalysts
Tweet Send to a Friend
RBC Capital analyst Daniel Busb reiterated the $135.00 price target on Abbvie (NYSE: ABBV) while maintaining a Outperform rating after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
